Main Article Content
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The AJTCCM is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
LWNdaba,MBChB,FCP(SA),DipIntMed(SA),DipHIV(SA),PGDipRenalMed (UK) ORCID for author Ndaba: https://orcid.org/0000-0002-2605-8134
Registrar, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa [email protected]
S A van Blydenstein, MB BCh, DCH, MMed (Int Med), FCP (SA), Cert Pulm (SA) Department of Internal Medicine, Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa
K E Hodkinson, MB BCh, MMed (Haem), FCPath (Haem) Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand and National Health Laboratory Service, Johannesburg, South Africa
Previtali E, Bucciarelli P, Passamonti SM, Martinelli I. Risk factors for venous and arterial thrombosis. Blood Transfus 2011;9(2):120-138. https://doi. org/10.2450/2010.0066-10
Ekim M, Ekim H, Yilmaz YK, Kulah B, Polat MF, Gocmen AY. Study on relationships among deep vein thrombosis, homocysteine & related B group vitamins. Pak J Med Sci 2015;31(2):398-402. https://doi.org/10.12669/pjms.312.6049
Undas A, Brozek J, Szczeklik A. Homocysteine and thrombosis: From basic science to clinical evidence. Thromb Haemost 2005;94(5):907-915. https://doi.org/10.1160/ TH05-05-0313
Marcucci R, Gori AM, Abbate R. Hyperhomocysteinemia: Cause or effect of disease? Blood 2005;105(8):3382-3383; author reply 3-4. https://doi.org/10.1182/ blood-2004-12-4610
FayWP.Homocysteineandthrombosis:Guiltbyassociation?Blood2012;119(13):2977- 2978. https://doi.org/10.1182/blood-2012-01-401513
RayJG,KearonC,YiQ,SheridanP,LonnE;HeartOutcomesPreventionEvaluationI. Homocysteine-lowering therapy and risk for venous thromboembolism: A randomized trial. Ann Intern Med 2007;146(11):761-767. https://doi.org/10.7326/0003-4819-146- 11-200706050-00157
Homocysteine Lowering Trialists’ Collaboration. Dose-dependent effects of folic acid on blood concentrations of homocysteine: A meta-analysis of the randomised trials. Am J Clin Nutr 2005;82(4):806-812. https://doi.org/10.1093/ajcn/82.4.806
Ventura P, Panini R, Tremosini S, Salvioli G. A role for homocysteine increase in haemolysis of megaloblastic anaemias due to vitamin B(12) and folate deficiency: Results from an in vitro experience. Biochim Biophys Acta 2004;1739(1):33-42. https://doi.org/10.1016/j.bbadis.2004.08.005